Heather Wakelee, MD, Stanford University, discusses the pros and cons of different durations of immunotherapy in non-small cell lung cancer (NSCLC) and the future outlook for patient-specific care.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Using preoperative chest CT scans, researchers identified novel preoperative biomarkers for lung cancer recurrence ...

A lung biopsy involves the removal of tissue or growths from the lungs. A doctor will use special devices, such as a fine needle, to remove the sample. A lung biopsy can help diagnose lung ...

Robotic bronchoscopy can help diagnose spots in the lungs when they are still small, catching cancer sooner and saving many ...

Liquid biopsy is ... fluids for cancer cells. Experts suggest that liquid biopsies are becoming more widely recognised, especially when it comes to diagnosing and treating lung cancer.

SGMC Health has successfully performed its first robotic-assisted lung biopsy using the state-of-the-art Ion robot. The health system said the procedure marked a major advancement in lung cancer ...

Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways.

Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites. The ...

Imagene's AI-based multigene panel for predicting non-small cell lung cancer biomarkers from biopsy images will be combined with Tempus' real-world data.

Small cell lung cancer (SCLC) accounts for about 15% of lung cancer cases and is categorized into limited and extensive stages. Treatment options include radiation, chemotherapy, and immunotherapy ...

and a biopsy. To determine if you have non-small cell lung cancer, your healthcare provider will likely begin by asking ...